市場調查報告書
商品編碼
1289652
醫療仿生學市場 - 2017-2027年全球行業規模、佔有率、趨勢、機會和預測,按類型、按應用、按公司和按地區分類Medical Biomimetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type, By Application, By company and By Region |
在2023-2027年的預測期內,全球醫學仿生學市場預計將出現令人矚目的成長。主要因素包括慢性病的發生率不斷增加,醫療仿生學的應用不斷增加,以及技術的廣泛發展,這些都遏制了市場的成長。生物仿生學是一個跨學科領域,包括生物學、工程學和化學。它被用於開發生物相容性材料,使醫療保健專家能夠監測和治療慢性疾病。它被用於再生醫學、組織工程和藥物輸送。支持市場成長的其他因素有:研發活動的增加,政府資金的增加,器官衰竭發病率的增加,發達和發展中經濟體醫療保健支出的增加,人口老齡化的增加,合併和戰略收購的數量增加,預期壽命的增加,以及對假體和植入物需求的增加。
慢性疾病,如心血管疾病、糖尿病和其他疾病的發生率越來越高,促進了全球市場的成長。由於久坐的生活方式和不健康的飲食選擇,人們正在遭受這些疾病的困擾,這推動了市場的成長。例如,根據美國疾病控制和預防中心(CDC)的數據,大約每40秒就有一個美國人死於心臟病發作。據估計,每年有80.5萬美國人心臟病發作,其中60.5萬是第一次發作。老年人口極易患上骨科疾病、心血管疾病以及神經系統疾病等疾病。因此,增加了醫療生物仿生學市場的成長。根據國家腎臟基金會的數據,在全球範圍內,65至74歲的人中有四分之一的女性和五分之一的男性患有慢性腎臟疾病。
醫療保健領域的快速進步,如機器人技術、3D列印技術和其他技術,正在推動市場的成長。在奈米技術、組織工程和其他領域擴大採用各種創新,預計將創造許多機會,抑制市場成長。採用奈米技術可以幫助發展個性化醫療、器官再生、整形手術和藥物輸送。例如,在美國,2020年,Veryan Medical公司推出了一種新穎的BioMimics 3D血管支架系統。 BioMimics是一個以在臨床試驗中取得超卓成果為目標的系統。
醫療領域對生物仿生學的需求不斷成長,推動了市場的成長。這要歸功於在牙科、心臟病學、骨科、眼科等各個領域的應用不斷增加。生物仿生學被用於治療各種疾病,如阿滋海默症、假肢、器官移植等。此外,醫療行業中無創程序(包括心電圖、CT掃描和超音波)中的醫用生物仿生技術的應用激增,預計將抑制市場的成長。例如,根據美國政府的數據,在2017年,全國大約進行了34,770例移植手術。
利用給定的市場數據,TechSci Research根據公司的具體需求提供定製服務。該報告可提供以下定製選項:
The global medical biomimetics market is anticipated to observe impressive growth during the forecast period 2023-2027. The major factors include growing occurrences of chronic diseases, increasing applications of medical biomimetics, and extensive development in technology that are curbing the growth of the market. Biomimetics is an interdisciplinary field that comprises biology, engineering, and chemistry. It is used for the development of biocompatible material, which allows healthcare experts to monitor and treat chronic diseases. It is used for regenerative medicine, tissue engineering, and drug delivery. The other factors supporting the market's growth are, rise in R&D activities, increasing favorable government funding, growing incidences of organ failure, the rising healthcare expenditure in developed and developing economies, rise in aging population base, growing number of mergers and strategic acquisitions, growing life expectancy, and rise in demand for prosthesis and implants.
The growing occurrences of chronic diseases, such as cardiovascular diseases, diabetes, and others, are bolstering the growth of the market globally. Owing to the sedentary lifestyle and unhealthy eating choices, people are suffering from these diseases, which propels the growth of the market. For instance, as per the Centers for Disease Control and Prevention (CDC), roughly every 40 seconds, an American die from a heart attack. It is estimated that 805,000 Americans have a heart attack every year, 605,000 of them for the first time. Geriatric populations are highly prone to diseases such as orthopedic diseases, cardiovascular diseases as well as neurological disorders. Thus, increasing the growth of the medical biomimetics market. According to the National Kidney Foundation, one in four women and one in five men aged between 65 to 74 years have chronic kidney disease across the globe.
Rapid advancements such as robotics, 3D printing technology, and others in the healthcare sector are surging the growth of the market. The increasing adoption of various innovations in areas of nanotechnology, tissue engineering, and others is expected to create numerous opportunities which curb the market growth. The adoption of nanotechnology can aid in the development of personalized medicine, organ regeneration, plastic surgery, and drug delivery. For instance, in the U.S., in 2020, Veryan Medical launched a novel BioMimics 3D vascular stent system. BioMimics is a system that aims for superb outcomes in clinical trials.
The growing demand for biomimetics in the medical sector is fueling the growth of the market. This is attributed to the increasing application in various fields such as dentistry, cardiology, orthopedics, ophthalmology, and others. Biomimetics is used for the treatment of various diseases, such as Alzheimer, prosthetics, organ transplants, and others. Moreover, an upsurge in the application of medical biomimetics in noninvasive procedures, including ECGs, CT scans, and ultrasound, in the healthcare industry is anticipated to curb the growth in the market. For instance, as per the U.S. government's data, in 2017, approximately 34,770 transplants were conducted in the nation.
The global medical biomimetics market is segmented into type, application, and company. Based on type, the market is divided into cardiovascular, orthopedic, ophthalmology, dental, and others. Based on application, the market is divided into wound healing, tissue engineering, drug delivery, plastic surgery, and others. In terms of country, the United States is expected to be a lucrative market in the forecast period due to rise in the adoption rate of novel technology in the country.
Wright Medical Group N.V., Abbott Laboratories, Inc., Blatchford Group (Chas. A. Blatchford & Sons Ltd), BioHorizons IPH, Inc., Biomimetics Technology Inc, SynTouch Inc., Vandstrom, Inc., Gelesis, Inc., BioTomo Pty. Ltd., and Hstar Technologies Corporation are some of the leading companies operating in the market.
In this report, global medical biomimetics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in Global Medical Biomimetics Market
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: